precisionmedicineonline1h
CBO Outlines Budgetary Considerations for Policies Focused on Sickle Cell Disease Gene Therapy
The Congressional Budget Office said policies to increase treatment uptake could affect Medicaid, Social Security, and other government programs.
clinicaladvisor.com4h
FDA Approval Increases Eligibility for Cystic Fibrosis Medication Trikafta
According to Vertex Pharmaceuticals, approximately 300 additional people with CF are now eligible to receive treatment.
Levi & Korsinsky Reminds Vertex Pharmaceuticals Investors of the Ongoing Investigation into Potential Violations of Securities Laws - VRTX
NEW YORK, NY / ACCESSWIRE / January 2, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vertex ...
FDA approves drugs from Vertex, Novo, Bristol Myers to wrap 2024
The agency’s main drug review office cleared 50 novel medicines last year, short of 2018’s record total but on the higher end ...
Biotech Stocks Facing FDA Decision In January 2025
As we enter the new year, all eyes are on the biotech companies awaiting key FDA decisions in January. In 2024, the FDA approved 50 ...
BioPharma Dive18h
10 clinical trials to watch in the first half of 2025
It’s similar in concept to Casgevy, an approved medicine from Vertex Pharmaceuticals, but uses a different form of DNA ...